Meanwhile, the activation of PI3K/AKT by IGF-1 can also inhibit ubiquitin-mediated degradation of proteins and apoptosis in skeletal muscle cells, reduce necrosis of muscle tissue, and thus alleviate the development of sarcopenia and its comorbidities (59, 60). Here, IGF1 is linked to sarcopenia.